Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia - Brazil
AUTOR(ES)
Tunes, Alessandro, Reis, Joice Neves, Terse, Regina, Santana, Maria Angélica, Diniz, Ana Lúcia, Barros, Tânia Fraga, Leal, Ana Karina Souza, Paixão, Vilma, Grassi, Maria Fernanda Rios
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2014-04
RESUMO
Lower airway infection is a major cause of morbidity and mortality in patients with cystic fibrosis. It is currently unknown if the infection of the upper airway can cause exacerbation of lower respiratory tract infection. This study aimed to determine the microbiological profile of the anterior paranasal sinuses outflow tract (middle meatus) of cystic fibrosis outpatients. The microbiological profile was defined using endoscopically directed middle meatal cultures. Paired middle meatal and sputum specimens were collected from 56 outpatients for aerobic cultures. A semi-quantitative leukocyte count of the middle meatal samples was performed. The median age of patients was nine years (3-20 years). Staphylococcus aureus (37%), Staphylococcuscoagulase-negative (25%), Neisseriac (14%), Pseudomonas aeruginosa (11%), andStreptococcus pneumoniae (7%) were the most prevalent microorganisms in the middle meatal cultures. Using the middle meatal leukocyte count, 16 out of 54 patients (29.6%) presented sinus infection. The most frequently identified pathogens in patients with sinus infections wereStaphylococcus aureus (10 patients), Pseudomonas aeruginosa (4 patients), andStreptococcus pneumoniae (3 patients). Agreement of paired middle meatal and sputum cultures was significantly higher among patients with infection in middle meatal (69%). The most common middle meatal pathogens were the typical cystic fibrosis spectrum. This suggests the potential for participating in post-nasal lower airway seeding.
Documentos Relacionados
- Microbiology of airway disease in patients with cystic fibrosis.
- Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil
- Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.
- Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis.
- Sputum Itraconazole Concentrations in Cystic Fibrosis Patients